Technical analysis of BrainsWay Ltd. (BWAY): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets.
Price Performance
| 1 month | -8.19% |
| 3 months | -9.60% |
| Year-to-date | +41.54% |
| 1 year | +67.62% |
| 3 years | +550.24% |
52-Week Range
| 52-week High | $17.40 |
| 52-week Low | $7.14 |
| Avg Volume (90d) | 125K |
Technical Indicators
| SMA 50 | $14.99 |
| SMA 200 | $13.49 |
| Beta | 1.10 |
| 30-day Volatility (annualised) | 48.3% |
| Price vs SMA 50 | -10.2% |
| Price vs SMA 200 | -0.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $8.43 | |
| 2025-11 | $8.74 | +3.7% |
| 2025-12 | $9.51 | +8.8% |
| 2026-01 | $11.69 | +22.9% |
| 2026-02 | $11.57 | -1.0% |
| 2026-03 | $13.29 | +14.9% |
| 2026-04 | $16.56 | +24.6% |
| 2026-05 | $15.89 | -4.0% |
| 2026-06 | $15.51 | -2.4% |
| 2026-07 | $15.23 | -1.8% |
| 2026-08 | $14.52 | -4.7% |
| 2026-09 | $13.46 | -7.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | $-0.02 | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
Price
| Price | $13.46 |
| Market Cap | $528M |
| Exchange | NASDAQ |
| Country | IL |
Valuation Ratios
| P/E Ratio | 54.41 |
| Price / Book | 6.67 |
| EV / EBITDA | 73.40 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.09 |
| Current Ratio | 3.59 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 2.87 |